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Abstract 
 
The nuclease domain of colicin E7 metallonuclease (NColE7) contains its active centre at the 
C-terminus. The mutant N4-NColE7-C* – where the four N-terminal residues including the 
positively charged K446, R447 and K449 are replaced with eight residues from the GST tag – 
is catalytically inactive. The crystal structure of this mutant demonstrates that its overall fold 
is very similar to that of the native NColE7 structure. This implicates the stabilizing effect of 
the remaining N-terminal sequence on the structure of the C-terminal catalytic site and the 
essential role of the deleted residues in the mechanism of the catalyzed reaction. 
Complementary QM/MM calculations on the protein/DNA complexes support the less 
favourable cleavage by the mutant protein than by NColE7. Furthermore, a water molecule as 
a possible ligand for the Zn2+-ion is proposed to play a role in the catalytic process. These 
results suggest that the mechanism of the Zn2+-containing HNH nucleases needs to be further 
studied and discussed. 
 
 
3 
Introduction 
 
The colicin E7 bacterial toxin of Escherichia coli belongs to the HNH family of 
metallonucleases.1, 2 It is expressed in E. coli under environmental stress to protect the host 
cell from related bacteria and bacteriophages. Only the nuclease domain (NColE7) of the 
protein enters the target cell, killing it through non-specific digestion of the nucleic acids.3 
The host cell is protected by the Im7 immunity protein, which co-expressed with the nuclease 
prevents the substrate binding.4 Crystal structures of NColE7 variants have been published in 
the presence or absence of its immunity protein, its metal ion cofactor, and the substrate 
DNA.3-11 The HNH motif in the active centre at the C-terminus of NColE7 contains conserved 
H and N amino acids in the HHX14NX8HX3H (amino acids 544-573) pattern.12 In this  - 
metal ion binding stretch H544, H569 and H573 act as ligands to the Zn2+-ion7, while H545 is 
supposed to generate the nucleophilic agent by deprotonating a water molecule.9, 13, 14 The 
catalytic mechanism is well established, with the exception of the protonation of the leaving 
group. The hypothesized pathways of this step are dependent on the quality of the metal ion in 
the active centre. The proton may be donated by a water molecule coordinated to a Ni2+-ion in 
NColE915 and to Mg2+-ion in Vvn16, related HNH nucleases. But for NColE7 the question 
remained open due to the absence of corresponding inner-sphere water molecule around the 
Zn2+-ion.7, 17 A putative proton chanel was suggested in the related colicin E9 nuclease18-20 
involving the amino acids that correspond to R538, E542 and H569 in colicin E7.4 However, 
H569 is bound the Zn2+-ion and the change in its protonation state would be unfavourable. 
Recently we have shown that the deletion of the N-terminal KRNK (446-449) 
sequence in NColE7 cancelled the catalytic activity21, in agreement with the previously 
demonstrated importance of R447 residue.13 The requirement of cooperation of the N- and C-
termini in NColE7 to exert its catalytic action may be developed into an allosteric activation 
control mechanism in a new artificial nuclease22. This property would be an advantage over 
the artificial chimeric nucleases created by fusion of e.g. zinc-finger or TALE proteins and the 
FokI nuclease domain23-25, where the allosteric control present in the native FokI26 is lost by 
exchanging its DNA binding domain with zinc-finger motifs. This may e.g. account for the 
known moderate cytotoxicity of zinc-finger nucleases designed for gene therapy.27 Therefore, 
it is important to understand the regulatory elements in artificial nucleases intended for in vivo 
applications.28 
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To better understand the role of the N-terminal sequence crystallization was 
undertaken of the N4-NColE7-C* protein – where the KRNK (446-449) sequence is 
replaced by a part of the GST purification tag lacking positively charged side chains. 
Previously its biochemical and biophysical properties were studied.21, 29 Here we present the 
structure determination to 1.7 Å resolution and a comparison to the previously published 
structures of NColE7. The possible influence of the mutation at the C-terminus was also 
elucidated by recloning the N4-NColE7 gene. The NColE7-DNA complexes can only be 
crystallized with an inactive form of the protein. To obtain information on the local 
geometries of the active site, we performed also QM/MM calculations.  
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Materials and methods 
 
Construction of the genes of the mutant proteins 
 
The gene encoding the N4-NColE7 mutant was cloned from the pQE70 plasmid (a generous 
gift of Prof. K.-F. Chak, Institute of Biochemistry and Molecular Biology, National Yang 
Ming University, Taipei, Taiwan12) and inserted into the pGEX-6P-1 (GE Healthcare) vector 
between the EcoRI/XhoI restriction enzyme sites (E/X) as described earlier21. The same 
fragment was also built in the pET-21a vector (Novagen) with the same restriction enzymes – 
(E/X)N4-NColE7 gene – and was recloned into the NdeI/XhoI sites (N/X) of the same 
vector: (N/X)N4-NColE7 gene. Since the insert DNA sequence contained a C-terminal stop 
codon, no C-terminal tags were expected to form. To check the effect of the C-terminal 
mutation, we have also cloned the gene of the NColE7-C* mutant into the pGEX-6P-1 vector. 
 
Protein expression and purification 
 
The expression and purification of the GST-N4-NColE7-C* protein (for the protein 
sequences see Fig. 1.) and the cleavage of the glutathione S-transferase (GST) affinity tag at 
the N-terminus by the human rhinovirus C3 protease30 was performed as described 
previously29. The expression of the GST-N4-NColE7, GST-NColE7-C* and (E/X)N4-
NColE7 proteins could not be carried out because of their toxicity to the host cell. On the 
other hand, the (N/X)N4-NColE7 protein was successfully overexpressed. The purification 
of this mutant was carried out using a Sepharose Fast Flow (GE Healthcare) ion exchange 
column equilibrated with phosphate-buffer (PBS: 0.14 M NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH = 7.7). The elution was carried out with a NaCl concentration 
gradient up to 1.0 M through 15 column volume in the same buffer. The protein was loaded 
onto a Source 30S (GE Healthcare) column using the same condition as mentioned above. 
The molecular mass of the purified protein was determined by ESI-MS as described by Czene 
et al 21. The theoretical average mass of the holo protein (N/X)N4-NColE7 with its first Met 
removed and in complex with one Zn2+-ion is 14563.3 Da, in excellent agreement with the 
ESI-MS results of 14563.0 Da. This indicates that the purified protein was in its Zn2+-bound 
form. 
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                                   450 
(GST)N4-NColE7-C* --------GPLGSPEFPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPEL 
(GST)N4-NColE7    --------GPLGSPEFPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPEL 
(E/X)N4-NColE7    MASMTGGQQMGRGSEFPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPEL 
(N/X)N4-NColE7                   MPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPEL 
(GST)NColE7-C*     ----GPLGSPEFKRNKPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPEL 
Colicin E7                     KRNKPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPEL 
Colicin E2                     KRNKPGKATGKGKPVGDKWLDDAGKDSGAPIPDRIADKLRDKEFKSFDDFRKKFWEEVSKDPEL 
Colicin E8                     KRNKPGKATGKGKPVGDKWLDDAGKDSGAPIPDRIADKLRDKEFKNFDDFRRKFWEEVSKDPEL 
Colicin E9                     KRNKPGKATGKGKPVGDKWLDDAGKDSGAPIPDRIADKLRDKEFKNFDDFRKKFWEEVSKDPDL 
Klebicin B                     PRNMPGTASGKGQNVGNNWMGGTSTGDGAPVPSQIADKLRGKAFGSFDSFCRAFWKAVAADPDL 
S-type Pyocin                  GRDLPGKVTGTGTDVEGSWLAGAGEGLGAPVPTRIADRLRDREFSSFDAFRRSFWQEVAADPEL 
Pyocin-S2 P. aer.              PRDVPGAATGKGQPVSGNWLGAASQGEGAPIPSQIADKLRGKTFKNWRDFREQFWIAVANDPEL 
TolA K. pneumoniae             PRNMPGTVSGKGQNVGNNWMGGASTGDGAPVPSQIADKLRGKTFGSFDSSRRAFWKAVADDSAL 
 
 
                                                                                     576 
(GST)N4-NColE7-C* SKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHQVNSSSGRIVTD 
(GST)N4-NColE7    SKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHRGK 
(E/X)N4-NColE7    SKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHRGK 
(N/X)N4-NColE7    SKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHRGK 
(GST)NColE7-C*     SKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHQVNSSSGRIVTD 
Colicin E7         SKQFSRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHRGK 
Colicin E2         SKQFKDSNKTNIQKGKAPFARKKDQVGGRERFELHHDKPISQDGGVYDMDNIRVTTPKRHIDIHRGK 
Colicin E8         SKQFNPGNKKRLSQGLAPRARNKDTVGGRRSFELHHDKPISQDGGVYDMDNLRITTPKRHIDIHRGQ 
Colicin E9         SKQFKGSNKTNIQKGKAPFARKKDQVGGRERFELHHDKPISQDGGVYDMNNIRVTTPKRHIDIHRGK 
Klebicin B         SKQFYPDDIERMKLGRAPTVRFRDSVGKRVKVELHHKVEISKGGDVYNVDNLNALTPKRHIEIHKGN 
S-type Pyocin      AGQFKKGNQGRMKKGLAPRVRELEQAGKRHSTELHHVDLISDGGEVYNIDNIHVVTPKQHVEIHSGK 
Pyocin-S2 P. aer.  SKQFNPGSLAVMRDGGAPYVRESEQAGGRIKIEIHHKVRIADGGGVYNMGNLVAVTPKRHIEIHKGGK 
TolA K. pneumoniae SKQFSEADINQMKAGRAPTADFLESVGKRVKIELHHEKEISQGGAVMDVDNIKALTPKNHIETHKGK 
 
Fig. 1 Multiple alignment of the amino acid sequences of the four designed mutant proteins. 
Rows 1: (GST)N4-NColE7-C*, 2: (GST)N4-NColE7, 3: (E/X)N4-NColE7, 4: 
(N/X)N4-NColE7 and 5: (GST)NColE7-C*, respectively. The amino acids in red are those 
originating from the expression vectors at the N-termini, and the result of the unexpected 
mutation at the C-terminus of the N4-NColE7-C* mutant. In the remaining 8 rows the amino 
acid sequences of nuclease domains of colicins and related toxins is shown for identification 
of the conserved N-terminal amino acids. Highly conserved residues are in bold, while bold 
and italic means conserved amino acids. 
 
Structure determination and refinement 
 
Details on the crystallization of N4-NColE7-C* and measurement of X-ray diffraction data 
have been described earlier in ref. 29. The overall symmetry of the diffraction pattern 
corresponds to the Laue class 3m and the systematically absent reflections are consistent with 
the space groups P3121 or P3221. The volume-to-mass ratio VM of 1.99 Å3 Da–1 and the 
corresponding solvent content of 35% match well a structure with one molecule per 
asymmetric unit (Mr ~16.2 kDa). It was possible to solve the structure by the Molecular 
Replacement method in the space group P3221 using MOLREP31 with the native NColE7 
structure (PDB entry: 1M085) as search model.  
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In the subsequent refinement of the structure, difficulties in modelling of the 
polypeptide chain were encountered in tracing the tagged N-terminus of the protein. The 
refined model in the space group P3221, which had the lowest acceptable penalty score in 
XDS32 contained density close the crystallographic twofold axis that could not be resolved 
into a meaningful chemical model and thus the space group published in ref. 29 was 
reconsidered. The N-terminus of the N4-NColE7-C* protein (Fig. 1) contains a GPLGSPEF 
additional sequence remaining after the cleavage of the GST tag during the protein expression 
and purification procedure. It was possible to trace the SPEF residues in this segment, found 
in a part of the crystal structure adjacent to the twofold axis. In the space group P3221 the first 
four (GPLG) residues would run into density of the same four residues of the symmetry 
related molecule (Fig. S1). Refinements in other possible space group were therefore 
attempted. The structure could be refined in P32 with a pseudo twofold axis replacing the 
crystallographic twofold axis in P3221. The refined model had a significantly lower Rfree and a 
comparable Rwork to the model obtained in P3221. In the space group C2, which would 
correspond to three molecules per asymmetric unit one of them is related to another molecule 
in the unit cell by a crystallographic twofold axis giving rise to similar problems as in the 
P3221. Due to the low redundancy refinement was not attempted in P1. The results are 
summarized in Table 1. 
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Table 1. Data processing in the three different space groups (details on the data collection 
experiment are given in ref. 29). The resolution is reduced from 1.6 to 1.7 Å in the 
refinement, to exclude poorly merging weak reflections in this range. Rmerge = 
, where Ii(hkl) is the intensity measurement for a given reflection 
and Ii(hkl)i is the average intensity for multiple measurements of this reﬂection. The values in 
parentheses correspond to the highest resolution shell. † With respect to Engh and Huber 
parameters.33 ‡ The three Ramachandran outliers34, 35 N461, L465 and D471 had well defined 
backbone density for the modelled conformations in both molecules.  
 
Space Group P32  P3221 C2 
Resolution range / Å 40-1.7(1.8-1.7) 40-1.7(1.8-1.7) 40-1.7(1.8-1.7) 
Unit-cell parameters 
a, b, c (Å) 
 
55.4, 55.4, 73.2 
 
55.4, 55.4, 73.2 
 
96.0, 55.4, 73.2 
α, β, γ (°) 90, 90, 120 90, 90, 120 90, 90, 90 
Total reflections 154648(24128) 154714(24240) 153962(24038) 
Unique reflections 53902(8489) 27529(4395) 78323(12217) 
Average multiplicity /Redundancy 2.9(2.8) 5.6(5.5) 2.0(2.0) 
Completeness (%) 97.3(93.0) 99.4(97.6) 94.2(90.6) 
 〈I/σ(I)〉 15.7(2.7) 22.8(3.9) 15.2(2.4) 
Rmerge (%) 4.1(39.3) 4.4(43.6) 3.2(36.8) 
Number of molecules per 
asymmetric unit 
2 1 3 
Refinement Rwork/Rfree 
0.200(0.290)/ 
0.234(0.331) 
0.191(0.260)/ 
0.277(0.320) 
0.210(0.230)/ 
0.250(0.300) 
R.m.s. deviation from ideality †    
Bonds / Å 0.01   
Angles / ° 1.28   
Number of atoms (protein) 4179   
Number of water molecules 104   
Number of bound Zn2+-ions 2   
Number of atoms in ions (2 
acetates, 9 sulfates, 2 chlorides) 55 
  
Ramachandran plot outliers ‡/ % 0.8   
 
After refinement with Refmac536 and manual rebuilding in COOT37, it was possible to 
obtain a chemically sound model that contains all residues of the sequence from 446G 
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(KRNK of WT NColE7 replaced by SPEF) to H573. Four N-terminal (442G, 443P, 444L, 
445G, which is part of the GST tag) and 12 C-terminal (Q574 – D585, this part of the 
sequence is indicated as the C* mutations) were not modelled due to disorder. The residual 
fragmented density close to the non-crystallographic twofold axis was modelled as water 
molecules. It was possible to trace the amino acids in the electron density up to those 
introduced by the random mutation in the C-terminus. Thus, the final structural model 
displays an intact  type metal binding site. In the refinement noncrystallographic 
symmetry (NCS) was not applied to allow for disruption of the twofold symmetry that relates 
the two crystallographical independent molecules. The difference and omit maps revealed the 
positions of the Zn2+-ion. Residual density was modelled as water molecules if they fulfilled 
the expected geometrical conditions. Furthermore nine sulfate, two chloride and two acetate 
ions were modelled in the difference electron density. The almost perfect twofold symmetry 
that relates the two molecules also with respect to the overall B-values, 27.3 Å2 and 27.1 Å2 
for the A and B molecule, respectively is not completely maintained in the position of the ions 
vide infra. 
 
QM/MM calculations on protein – DNA complexes 
 
The protein setup was performed based on the crystal structures 3FBD10 and 1M085 as well as 
the construction of the QM/MM system, following the recommended protocol38, 39 that is 
almost identical to those used in our previous QM/MM studies.40-42 The quantum system 
(System 1) consisted of 169 atoms for NColE7 and 156 for ΔN4-NColE7 (Fig. S2) including 
the Zn2+-ion, H544, H545, H569, H573, V555 and the sidechain of R447 (only for NColE7). 
The MM part was divided into System 2 (surrounding of the quantum region) that is allowed 
to move in the QM/MM minimizations and System 3 (the rest of the protein) that is kept 
fixed.  
The QM/MM calculations were carried out employing a modified version of the 
ComQum program.38, 39, 43 The Turbomole 6.3 program44 was used for the quantum chemical 
calculations carried out using DFT method and implying Perdew-Burke-Ernzerhof (PBE) 
functional45 and Ahlrich’s def2-SVP basis set.46 Resolution of the identity (density-fitting) 
was used to expedite the DFT calculations. MM calculations were carried out in the AMBER 
8 program package (sander module) and the ff0347, 48 force field (parm99 set in Amber).  
Further details are deposited in the Electronic Supplementary Information (see 
chapters S1-S3 and References therein). 
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PDB code 
 
The coordinates of the N4-NColE7-C* refined in space group P32 have been deposited in 
the PDB with the reference: 3ZFK. 
 
Results  
 
Description of the structure of the ΔN4-NColE7-C* protein 
 
The two protein chains in the final model are virtually identical, the superimposition of their 
backbones gives an rmsd (root mean square deviation) 0.05 Å (Fig. S3). It is noteworthy that 
the four residues of fused GST-tag that have replaced the four deleted residues (KRNK) in the 
intact NColE7 sequence, are visible in the electron density. The close interactions between the 
N-termini of the A and B molecules illustrated in Fig. 2a involve only the first four amino 
acids of the tag. Mass spectra and N-terminal analysis has verified that the protein is intact. 
However, in the C-terminus only the residues that are part of the NCo1E7 are visible in the 
electron density. Inspection of the structure shows that there is sufficient space in the crystal 
packing to accommodate the last 12 residues in disordered conformations.  
Electron densities interpreted as chloride ions are located in similar positions on the 
surface of the two molecules, their neighbors are G455 and three water molecules, all in the 
expected hydrogen bond distances. Fig. 2a shows how the molecules related by the non-
crystallographic twofold axes are linked by sulfate ions that neutralize positively charged side 
chains. One of these (marked in red) is located on the non-crystallographic twofold axis. Two 
of the sulfate ions serve as ligands to the bound Zn2+-ions. The sulfate ions associated with the 
molecules A and B conform with the overall twofold symmetry that relates the two molecules. 
This is not the case for the acetate ions. The two acetate ions that were identified in the 
electron density are both bound to molecule B, where they form hydrogen bonds to R496 and 
S550. It is worth mentioning that the anions bound to the B molecule nicely mimic the 
predicted binding sites of the DNA phosphodiester groups (Fig. 2b). 
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(a) 
 
(b) 
Fig. 2 a The two independent molecules A and B of N4-NColE7-C* with bound ions. 
Molecule A is in the left of the figure, and molecule B to the right. Their N-termini are shown 
in yellow and the C-termini in bright blue. Zn2+-ions are illustrated as grey spheres, chloride 
ions as green spheres; sulfate and acetate ions are shown in a stick representation. The sulfate 
ion drawn in red bound to molecule B is a crystallographically related match of the sulfate ion 
in the top left bound to molecule A. b Molecule B with its bound anions. The side chains of 
the hydrogen bond partners of the acetate ions are shown in a stick representation. The 
arrangement of the two acetate ions (bound to the labeled residues) and two sulfate ions close 
to the active site of molecule B are bound similarily to the phosphodiester groups of one of 
the bound DNA chains in the structure 2IVH.8  
 
Some distinct interactions involving the amino acids of the truncated N-terminus could 
be identified in the crystal structure of N4-NColE7-C*. One of these involve the highly 
conserved W464 located in a hydrophobic pocket formed by the residues of the N-terminal 
loop (L465, P475, V476, P477), the central part of the protein (F499, W500, L509, F513) and 
the HNH motif (V563) as shown in Figs. 3a and b. Residues from the N-terminus interact 
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with the HNH loop and with one of the β-sheets within the C-terminal HNH motif as shown 
in Fig. 3c. These interactions make the N-terminal loop fill the space (Fig. 3d) between the 
HNH motif and the central part of the protein including nonspecific DNA and Im7 binding 
helices. 
 
 
Fig. 3 Interactions of the N-terminal loop. a The vacuum electrostatic surface of the 
surroundings of W464. b The hydrophobic environment around W464. c The identification of 
possible hydrogen bonds formed between the amino acids of the N-terminal loop and those of 
the HNH motif. d Shape complementarity of the N-terminal loop between the C-terminal 
HNH motif and the central parts of the protein (grey). In b, c and d the N-terminus is colored 
in blue, while the HNH motif is red.  
 
These interactions – most of them found in the other known NColE7 structures – may 
stabilize the active site. This is supported by our recent studies on the HNH motif itself 49 on 
the ΔN25-NColE7 mutant lacking the major part of the N-terminal loop21, as well as on the 
NColE7 triple mutant including T454A, K458A and W464A mutations50. 
Figure 4 shows the environment of the Zn2+-ions bound in the two molecules, A and 
B. Both are coordinated by three histidine residues and a sulfate ion. The C-terminal H573 is 
poorly defined in both molecules. The refined B-value for the Zn2+-ion is significantly higher 
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in molecule A than in molecule B, 40.54 and 24.57 respectively. The excess residual density 
at the position of the Zn2+-ion in molecule A could indicate a disorder that has not been 
sufficiently well modeled. The closest water molecule to Zn2+ is W2072, in a distance of 4.0 
Å. The B-value of the Zn2+-ion in molecule B is significantly lower and residual density is 
found 1.25 Å away from the Zn2+-ion. Furthermore a water molecule (W2065) is located in 
the second coordination sphere of Zn2+, in a distance of 3.9 Å. 
 
  
 
Fig. 4 The surroundings of Zn2+-ion in the active site of the two molecules. A Sigma-A 
weighted 2Fobs–Fcalc electron density map at 1.5 sigma (0.48 e–/Å3) is shown in blue and Fobs-
Fcalc difference map electron density at 3.0 sigma cut-off (0.37 e–/Å3) in green and red, 
respectively for the a A and b B molecule in the crystal structure of N4-NColE7-C*. The 
peak in he difference density 1.25 Å away from the Zn2+-ion was not modelled.  
 
Computational Results: QM/MM calculations - comparison of the catalytic centre from 
the calculations and crystal structures 
 
QM/MM calculations provide a valuable complementary method for the local structural 
details of proteins (e.g.51, 52 were performed for the ΔN4-NColE7-Zn2+/DNA and the active 
NColE7-Zn2+/DNA model structures. We expected that this shall predict the active state of 
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the protein in complex with Zn2+ and DNA, and gives important atomic details (position of 
hydrogen atoms, protonation states, etc.).  
 
Fig. 5 a The superimposed structures of NColE7/DNA (orange) and ΔN4-NColE7/DNA 
(blue) complexes, both optimized with QM/MM method. b The active centre of the 
corresponding structures: the Zn2+-ion is pentacoordinated with three His residues, one water 
molecule and an oxygen atom of the scissile phosphate in its coordination sphere. 
 
As can be seen in Fig. 5a, the overall optimized structure of the two proteins is similar 
whereas small structural differences are confined to the active centre. These differences are 
seen in the orientations of the metal coordinating histidines, notably H544 and the position of 
the metal ion in ΔN4-NColE7. The bond angles to ligands in the coordination sphere of the 
metal ion are more significantly influenced than the bond lengths. Surprisingly, in both 
QM/MM optimized structures the Zn2+-ion in the active centre became pentacoordinated in a 
slightly distorted trigonal bipyramidal geometry (Fig. 5b).  
The deletion of the N-terminal KRNK residues likely causes changes also in key steps 
of the catalysis. The supposed general base H545 is tilted in the modelled ΔN4-NColE7 
structure (Fig. 6a), as compared to the optimized NColE7/DNA complex structure. The 
catalytic water molecule activated by this residue is in different orientation in the two 
optimized structures. When R447 is present, it serves as a hydrogen bond donor to this water 
molecule in the optimized structure.  
Changes in the active site of NColE7 affected the substrate DNA chain. One of the 
two bases at the scissile phosphate (CYT11) is tilted in the NColE7/DNA complex (Fig. 6a) 
and is no longer coplanar with its guanine pair. This strain in DNA may facilitate its 
hydrolytic cleavage. In contrast, in the ΔN4-NColE7/DNA optimized structure the CYT11 is 
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nearly coplanar to its pair on the opposite strand. We also noted a difference in the P–O3’ 
scissile bond lengths in the optimized structures (Fig. 6b): the increased length in the presence 
of NColE7 suggests higher probability of the cleavage by the WT enzyme compared to the 
ΔN4-NColE7mutant.  
 
 
Fig. 6 a DNA binding of NColE7 (orange) and ΔN4-NColE7 (blue) in the QM/MM 
optimized structures. Major differences appear in the position of the H545 and its hydrogen-
bonded water molecule and in the position of the plane of CYT11. b P–O bond lengths within 
the scissile phosphodiester bond in the same structures.  
 
Discussion 
 
Comparison of the N4-NColE7-C* crystal structure with other available NColE7 
structures 
 
Fig. 7a shows that the mutations at the N- and C-termini did not influence significantly the 
N4-NColE7 fragment (residues 450-573) of the structure compared to NColE7 (PDB entry: 
1MZ86) the all-atom rmsd being 0.23 Å. Accordingly, the lack of DNase activity is not due to 
conformational changes but it is directly related to the mutations. The only clear difference 
was observed in the electrostatics: N4-NColE7-C* is significantly less positive than NColE7 
(Fig. S4). 
The structure and relative position of the N-terminus are not affected by DNA or Im7 
binding in NColE7 variant crystal structures.3-10 It also remained unchanged in the N4-
NColE7-C* protein upon the mutation of the KRNK sequence at the N-terminus as Fig. 7b 
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shows. This confirms that additional interactions exist between the N-terminal loop and the 
rest of the protein, which are responsible for keeping the positive charges at the N-terminus 
close to the catalytic centre. 
 
 
Fig. 7 a Structural alignment based on the identical amino acids of the N4-NColE7-C* 
(blue; PDB code: 3ZFK) and WT NColE7 (orange; PDB code: 1MZ86) shows good 
agreement between the structures of the two proteins. b Structural alignment of the N-
terminal loops in selected NColE7 domains including the PDB structures 1M085, 1MZ86, 
1PT33, 1ZNS7, 1ZNV7, 7CEI4, 2IVH8, 2JAZ9, 2JB09, 2JBG9 and 3FBD10 all in light grey and 
the Δ4-NColE7-C* in blue.  
 
In N4-NColE7-C* it was also possible to identify all the hydrogen bonds formed by 
the conserved N560 with the backbone atoms of E546, K547, G557 and D557 in the flexible 
HNH loop (Fig. S5).9 N560 has a high impact on the catalytic activity, since it fixes the 
position of the general base H545.9, 13 The position of the four active site histidines is well 
preserved in most of the NColE7 structures. The only exceptions are the DNA complexes of 
the H545 mutated inactive enzyme (1ZNS7, 2IVH8) – where one or more His side-chains are 
tilted (Fig. 8a). Similarly, the rotation of the H573 side-chain imidazole ring by ~ 17 degrees 
is observed in the active site of N4-NColE7-C* relative to the corresponding imidazole in 
1M08 NColE7 structure.  
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Fig. 8 a Comparison of the arrangement of the metal ion and coordinating histidine residues 
in the active site of ΔN4-NColE7-C* (in blue) with other NColE7 structures (NColE7 in 
orange: 1M085; NColE7/Im7 in yellow: 1MZ86, 1ZNV7, 7CEI4, 2JAZ9, 2JB09, 2JBG9; 
NColE7/DNA in brown: 1PT33, 2IVH8, 1ZNS7, 3FBD10). b Orientation of the phosphate ions 
(1M08, 1MZ8, 2JAZ) and the sulfate ions (2JBG and the ΔN4-NColE7-C*) applying the 
same color coding. 
 
A slight shift in the position is seen for the Zn2+-ion and the substrate mimicking 
sulfate ion in N4-NColE7-C* relative to the the Zn2+ containing NColE7 structures in Fig. 
8b. This did not affect the strong metal ion binding of N4-NColE7-C*.21 By contrast ΔN25-
NColE7 and T454A/K458A/W464A-NColE7 mutants with modified N-terminal sequences 
showed impaired Zn2+-binding ability due to the structural changes of the active centre.21, 50 
Consequently, we suggest that the interactions between the N-terminus and the HNH motif 
are essential for the mutual stabilization of their structure and for the proper folding of the 
catalytic centre. 
The comparison of the N4-NColE7-C* and other published crystal structures to the 
QM/MM computational models of NColE7/DNA and N4-NColE7/DNA can give a deeper 
insight to the catalytic differences in the active centre. While the Zn2+-coordination is similar 
in the compared structures, as shown by Zn2+-donor atom distances listed in Table 2, the 
difference between the P-O(3’) and P-O(5’) bond lengths of the scissile phosphate is only 
significant in the optimized active structure, but not in the crystal structures. It must be, 
emphasized that all the experimental results were obtained for inactive forms of the protein, 
i.e. either the metal ion was absent or a functional residue was mutated. This difference 
between the computed NColE7/DNA and ΔN4-NColE7/DNA complexes may indicate the 
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slight changes in the active centre that finally contribute to the loss of nuclease activity upon 
deletion of the N-terminal positively charged residues. 
 
Table 2. Comparison of the NColE7/DNA crystal structures with the QM/MM optimized 
structures and the 3ZFK structure. Bond lengths in Å. 
 
Structures 
Zn2+- 
O(DNA) 
Zn2+- 
H544 
Zn2+- 
H569 
Zn2+- 
H573 
P-O 
(3') 
P-O 
(5') 
ΔP-O  
(3'-5') 
Ref. 
1PT3 (without Zn2+) - - - - 1.607 1.588 0.019 3 
3FBD (without Zn2+) - - - - 1.616 1.594 0.022 10 
2IVH (H545Q) 1.769 2.039 2.136 1.837 1.604 1.596 0.008 8 
1ZNS (H545E) 2.017 1.798 1.941 2.047 1.591 1.579 0.012 7 
3ZFK (without DNA) A - 1.977 2.187 2.287 - - - this work 
3ZFK (without DNA) B - 1.672 2.073 2.090 - - - this work 
ΔN4-NColE7/DNA calc. 2.003 2.081 2.147 2.044 1.643 1.617 0.026 this work 
NColE7/DNA calc. 2.067 2.095 2.148 2.117 1.654 1.614 0.040 this work 
 
The Zn2+-ion and the positively charged N-terminal amino acids in the active site – new 
possible roles in the catalytic function 
 
In the crystal structure of ΔN4-NColE7-C* the B molecule had a Zn2+-binding site with 
significant residual density in the vicinity, at a difference map peak of 1.25 Å, as shown in 
Fig. 2. The major difference lies not in the protein monomers, but in the metal ions: Zn2+-ion 
B402 is less rigid and with a significantly lower (62%) atomic displacement parameter than 
the one of Zn2+-ion in the A molecule. The metal-ligand coordination is essentially the same 
in both molecules, but our modelling studies hinted at the coordination of an additional water 
molecule (Fig. 4). This is in agreement with the results of the QM/MM calculations. In the 
optimized structures (Fig. 6. a) a water molecule that was weakly bound (R(Zn–O) = 3.7 Å) in 
the starting structure approached the metal ion to 1.9 Å and 2.0 Å for ΔN4-NColE7 and 
NColE7, respectively. Such water molecules may be activated during the catalytic process to 
serve either as general acid or base. This model is consistent with an artificial nuclease 
system53, 54 and a similar type of coordination was observed experimentally in an NColE9 
crystal structure (1FSJ55). It is worth mentioning that in the crystal structure of ΔN4-NColE7-
C* H2O(2072) in the A molecule and H2O(2065) in the B molecule are located ~ 4.0 Å from 
the Zn2+-ion. 
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 Sequence comparison of related colicin and pyocin bacterial toxins showed that the 
arginine corresponding to R447 in colicin E7 is highly conserved (Fig. 1). Crystal structures 
of HNH nucleases showed that an arginine stretches into the active site (e.g. R447 in 
NColE75, 6, 10, R5 in NColE956, R99 in Vvn16, R57 in Sm endonuclease57 and R93 in Nuclease 
A58. The  distance from the side chain of this arginine to the metal ion located in the active 
centre is ~ 6-7 Å in the presence of DNA or a phosphate/sulfate ion situated between the 
positively charged residues, and > 10 Å in the absence of it. Based on Vvn crystal structures it 
was hypothesized that the arginine side chain binds and stabilizes the cleaved DNA to 
decelerate the reverse reaction16, 17. In NColE920 and in Sm endonuclease59 related HNH 
nucleases the arginine corresponding to R447 in NColE7 was proposed to stabilize the 
pentavalent transition state. The R447A mutation in NColE7 reduced the in vitro DNase 
activity to ~ 15% of the initial value13 supposed to be due to the decreased DNA binding 
affinity. In contrary, we have recently shown that the mutations of the positively charges 
within the KRNK (446-449) sequence do not significantly affect the strength of the DNA 
binding.60 This study also demonstrated that the positively charged lysines can partially 
replace the missing arginine in its function. 
Surprisingly, precise location of R447 in the presence of the DNA has only been 
determined in the 18bp DNA-D493Q NColE7 mutant complex10, and it was not possible to 
locate it in the three other crystal structures of DNA complexes.3, 7, 8 In this complex R447 
clearly interacts with the phosphodiester group of the DNA molecule. In spite of the close 
contacts, this residue has unusually high temperature factors 60-70 Å2 compared to those of 
the rest of the molecule (Fig. S6) indicating its high flexibility. The experiments on cytotoxic 
behavior of the mutants (see later) also demonstrated that even the location of the positively 
charged amino acid residue in the amino acid sequence close to the N-terminus is not strictly 
determined.  
Considering the above observations we can not exclude that the flexible arginine side-
chain mediates the proton transfer in NColE7. After protonating the leaving group it may 
become instantly re-protonated by H545. These two residues get close (Fig. 9) to each other 
and a water-mediated hydrogen bond is formed between them during the catalytic cycle. The 
initial source of the proton on H545 is the water molecule, which has to become deprotonated 
to perform the nucleophilic attack at the partially positively charged phosphorus atom. This 
would be in agreement with the recently proposed shuttle mechanism according to which the 
leaving group is protonated by the hydrogen ion originating from the same water molecule 
that initiated the nucleophilic attack.61 
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H544
H545
H573
H569
Zn2+
R447
R538
E542
 
Fig. 9 Short interatomic distances reflecting possible hydrogen bonds in the active site of 
N4-NColE7-C* molecule A (blue) in comparison with NColE7 (PDB: 1M08, in orange). 
The hydrogen bonds among R538, E542 and H569 (the H569 residue also binds the Zn2+-ion) 
form a putative proton channel.  
 
The above mechanism would be similar to the one found in a serine recombinase-
mediated DNA cleavage.62 Although arginine is rarely mentioned in the literature to behave 
as an acid but the environment of an enzyme active site can significantly shift the pKa values 
of critical residues. It can be considered plausible in biological systems63, especially in the 
presence of a basic leaving group as it is the 3’-alcoholate ion. This would provide a 
reasonable answer to the still unsolved but intriguing question about the identity of the 
general acid that protonates the leaving group in NColE7. It shall also be mentioned that the 
multiple roles of R447 can be partially replaced by other positively charges, such as lysine 
side-chains or the N-terminal amino group in a suitable position. 
 
The effect of the N- and C-terminal mutations on the cytotoxicity 
 
Toxic variants of NColE7 kill the bacterial cell through their nuclease activity already during 
the cloning process due to the minor level of expression in the applied cloning systems.22, 64 
Taking advantage of this we can obtain information on the catalytic activity of an NColE7 
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mutant already in the early stage of the experiments. At the same time, the minuscule 
probability to obtain a gene of erroneous sequence, resulting in an inactive mutant, is 
increased. These mutations may reveal the necessity of each amino acid residue and may 
affect the protein structure, metal ion or DNA binding or the catalytic process itself. This 
event led to a C-terminal modification resulting in extra 9 amino acids within the inactive 
(GST)ΔN4-NColE7-C* protein. This points to the fact that the expected GST-N4-NColE7 
protein was cytotoxic for the E. coli cells. 
To understand this and to investigate the impact of the mutations at the two termini of 
the GST-N4-NColE7-C* protein we have recloned the N4-NColE7 gene into the pET-21a 
vector as described in Materials and methods (the expected sequences are depicted in Fig. 1). 
While the (E/X)N4-NColE7 variant was cytotoxic, the (N/X)N4-NColE7 protein of correct 
sequence was successfully overexpressed in E. coli as a Zn2+-bound protein (the ESI-MS 
proof of the metal ion binding is shown in Fig. S7) similarly to the GST-N4-NColE7-C* 
mutant. The latter protein was proven to bind both Zn2+-ions and DNA in vitro strongly21 
thus, it is the lack of another feature that allows for expression without cytotoxic effects. 
The data collected in Table 3 show that the ΔN4-NColE7 with an arginine close to the 
N-terminus in similar position to the WT NColE7 are cytotoxic. The only exception is the 
active GST-ΔN4-NColE7 nuclease. However, in this protein the GST fusion tag carries 
several positive charges both on the surface and in the linker region (Fig. S8). One of these 
may allow for the catalytic process in GST-N4-NColE7, but not in GST-N4-NColE7-C*. 
The access of the bulky GST tag to the active site is most probably prohibited by the newly 
formed C-terminus in the latter protein. In parallel to this the same C* mutation can not 
prevent the GST-NColE7-C* to be cytotoxic, providing further proof on the importance of the 
KRNK sequence.  
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Table 3. The correlation of the cytotoxic activity with the modifications at the N- and C-
termini of the NColE7 in different mutants in this study. aThere is no positively charged 
residue within a distance of 10 amino acids of the original position of the R447. bThe gene of 
ΔN4-NColE7 was inserted into a plasmid that added a short sequence containing the arginine 
at position R445. 
 
 
Position of R  
near the N-terminus 
C-terminal  
modification 
Cytotoxicity 
NColE7 447 - + 
GST-N4-NColE7-C* - a + - 
GST-N4-NColE7 - a - + 
(E/X)N4-NColE7 445b - + 
(N/X)N4-NColE7 - - - 
GST-NColE7-C* 447 + + 
 
Conclusions 
 
The truncated mutant of NColE7 nuclease, lacking the positively charged KRNK amino acid 
string at the end of the N-terminal sequence proved to be catalytically inactive. The presence 
of the N-terminal loop – distant in the sequence from the catalytic centre – playing an 
intramolecular allosteric role in the enzymatic process, as found in NColE7, is a fascinating 
phenomenon to study. This feature of NColE7 may be applied in the engineering of controlled 
artificial nucleases. The crystal structure of the ΔN4-NColE7-C* mutant, determined at 1.7 Å 
resolution revealed direct information about the structural role of the remaining N-terminal 
sequence, and it also provided indirect information on the role of the deleted KRNK (446-
449) string. The additional C-terminal modification was shown to control the enzymatic 
activity by preventing the distal positively charged amino acids on a bulky chains to approach 
the catalytic site.  
As the structure of ΔN4-NColE7-C* does not significantly differ from the structures 
determined so far for NColE7 we can conclude that the lack of its catalytic activity is not due 
to a change in the overall structure. The extensive interactions between the unchanged part of 
the N-terminal loop and the rest of the protein are not influenced by the deletion of the KRNK 
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amino acid sequence. These interactions may contribute to the mutual stabilization of the N-
terminal loop and the catalytic centre.  
The cytotoxic activity of the designed mutant proteins indicated that it can be 
associated with a positively charged residue close to the N-terminus. R447 could not be 
modeled in the majority of NColE7 variant crystal structures, which indicates a great 
flexibility. It leads us to propose that R447 beside the previously suggested functions may 
also behave as a flexible general acid that assist in the transfer of the proton from the general 
base to the leaving group. According to the QM/MM calculations the presence of R447 also 
facilitates the distortion of the substrate DNA chain promoting the hydrolysis of the scissile 
phosphodiester group. QM/MM calculations pointed out that in the active NColE7-DNA 
complex – that cannot be studied by crystallographic methods due to the catalytic reaction – 
the bond length of the scissile bond in contrast to the crystal structures of inactive variants is 
elongated, and the plane of the nucleobase at the cleavage site is tilted. These phenomena 
were not observed in the optimized ΔN4-NColE7 structure.  
Both the QM/MM calculations and the careful inspection of the crystal structure 
revealed the possibility of the coordination of a water molecule to the Zn2+-ion as the fifth 
ligand. Such a metal ion activated water molecule may participate in the catalytic process as a 
nucleophilic reagent after passing its proton to an amino acid side-chain of the protein, or as a 
general acid providing its proton in the final step of the reaction.  
Our results showed that the mechanism of action of NColE7 require some revisions. 
The essential catalytic role of the positively charged amino acids (such as R447 in the WT 
enzyme), as well as the presence of a water molecule as the fifth ligand in the Zn2+ 
coordination sphere has to be considered. The detailed description of the particular role of 
these residues will be possible upon further combined experimental and computational 
studies. 
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